Search hospitals > Texas > Amarillo
Texas Tech University Health Sciences Center-Amarillo
Claim this profileAmarillo, Texas 79106
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Lymphoid Leukemia
Conducts research for Acute Lymphoblastic Leukemia
124 reported clinical trials
5 medical researchers
Summary
Texas Tech University Health Sciences Center-Amarillo is a medical facility located in Amarillo, Texas. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Lymphoid Leukemia, Acute Lymphoblastic Leukemia and other specialties. Texas Tech University Health Sciences Center-Amarillo is involved with conducting 124 clinical trials across 236 conditions. There are 5 research doctors associated with this hospital, such as Samer Zaid Kaylani, Smita Bhaskaran, Alison Lunsford, MD, and Christine Garner, PhD.Area of expertise
1Leukemia
Global LeaderBCR-ABL1 fusion positive
ABL-class fusion positive
Stage II
2Tumors
Global LeaderStage I
Stage II
Stage IV
Top PIs
Samer Zaid KaylaniTexas Tech University Health Sciences Center-Amarillo18 years of reported clinical research
Studies Leukemia
Studies Tumors
12 reported clinical trials
45 drugs studied
Smita BhaskaranTexas Tech University Health Sciences Center-Amarillo4 years of reported clinical research
Studies Tumors
Studies Cancer
11 reported clinical trials
45 drugs studied
Alison Lunsford, MDTexas Tech University Health Sciences Center3 years of reported clinical research
Studies Pituitary Dwarfism
Studies Endocrine Disorders
1 reported clinical trial
1 drug studied
Christine Garner, PhDTexas Tech University Health Sciences Center2 years of reported clinical research
Studies Gestational Weight Gain
Studies Postpartum Depression
1 reported clinical trial
2 drugs studied
Clinical Trials running at Texas Tech University Health Sciences Center-Amarillo
Ovarian Tumors
Testicular Carcinoma
Ovarian Carcinoma
Ovarian Choriocarcinoma
Germ Cell Tumors
Testicular Choriocarcinoma
Testicular Tumor
Tumors
Wilms Tumor
Kidney Wilms Tumor
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Texas Tech University Health Sciences Center-Amarillo?
Texas Tech University Health Sciences Center-Amarillo is a medical facility located in Amarillo, Texas. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Lymphoid Leukemia, Acute Lymphoblastic Leukemia and other specialties. Texas Tech University Health Sciences Center-Amarillo is involved with conducting 124 clinical trials across 236 conditions. There are 5 research doctors associated with this hospital, such as Samer Zaid Kaylani, Smita Bhaskaran, Alison Lunsford, MD, and Christine Garner, PhD.